So look, I actually think again, I always say the US is the most dynamic. But I think, you know, Europe is an interesting market. Post-April 2nd, they've been less affected. They're trading better. They don't have some of the supply chain issues. So you know, I think transactions in Europe haven't hiccuped as much. There are obviously fewer transactions to begin with. But they're not directly in the line of fire right now. And there have been some indications that the economies in Europe are gonna spend some capital and take some actions that I think could be actually positive for Europe. So I'll say that. That's a three-week read. Remember, I'm reading the tea leaves while they're still, you know, falling off the tree, I would say. Asia, I haven't seen. Obviously, China, Asia is gonna be very different. And I don't know that I have enough data to tell you what happens to Hong Kong, Asia, Japan, Asia, by the way, seems pretty there's a lot of optimism around Japan as a market. But, again, we're early on, and I assume China's gonna be you know, there's gonna be without resolution. There'll be a lot of difficulties out of China. I know you said big versus small. What was the second I think if you're it depends on the sector. Right? If you're American-based, if you're not a supply chain-oriented transaction, a lot of that's going forward. There is a lot of financing available. The private credit is out there looking to put capital to work. The bank market is a little more difficult. But private credit is out there. And if you have a healthcare business in the United States that's not affected by the supply chain, you're probably gonna get your transactions done, and that's both strategic and sponsor. I would actually think that it's more of what sector you're talking about than strategic versus sponsor. Are you affected and when I say affected, I think there are people now trying to figure out, you know, kind of third derivatives of if, you know, if there's no containers shipped for another month because of the tariffs. You know, you're starting to think a second and third derivative. So I think the effects might get more widespread than people think. But right now, I don't see a big difference in those so long as you're talking about the effect of the supply chain. And I would say that kinda goes to your big versus small. Which it's very hard to have, you know, you don't have a lot of big companies that don't have a supply chain that, you know, is complicated. By just by the characterization of being large companies, they have a very good chance of encountering a supply chain issue that would cause a transaction to go on hold. I think it's because it's such a digital outcome on the policy it's very hard to underwrite. People, companies, and sponsors can underwrite uncertainty. But not when it's digital. And in the total outcome of the administration, I think. So, yeah, a lot of those are gonna go on hold, and it's gonna it really starts with is your supply chain affected are you affected by the supply chain? I think that's where it breaks.